"HER2陽性唾液腺がんに対するトラストズマブとドセタキセルの多センター第2相試験"に対する著者の回答
Satoshi Kano1, Ichiro Kinoshita2, Hirotoshi Dosaka-Akita2
1Department of Otolaryngology-Head and Neck Surgery, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, N15, W7, Kita-ku, Sapporo, 060-8638, Japan.
Japanese journal of clinical oncology
|September 1, 2025
まとめ
No abstract available in PubMed .
さらに関連する動画
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
7.3K
10:38Establishing 3-Dimensional Spheroids from Patient-Derived Tumor Samples and Evaluating their Sensitivity to Drugs
Published on: December 16, 2022
2.3K
